Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 847632, 7 pages
http://dx.doi.org/10.1155/2010/847632
Clinical Study

Levels of Salivary IFN-gamma, TNF-Alfa, and TNF Receptor-2 As Prognostic Markers in (Erosive) Oral Lichen Planus

1Department of Oral Medicine, Periodontology and Diagnosis, Faculty of Oral and Dental Medicine, Cairo University, 43 Zahraa Street, Dokki, Giza 12311, Egypt
2Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, Al Azhar University, Cairo, Egypt
3Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Egypt

Received 11 October 2010; Revised 12 December 2010; Accepted 28 December 2010

Academic Editor: Jan van Amsterdam

Copyright © 2010 Noha A. Ghallab et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. B. Ismail, S. K. Kumar, and R. B. Zain, “Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation,” Journal of Oral Science, vol. 49, no. 2, pp. 89–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. B. Sugerman, N. W. Savage, L. J. Walsh et al., “The pathogenesis of oral lichen planus,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 4, pp. 350–365, 2002. View at Google Scholar · View at Scopus
  3. A. Sklavounou-Andrikopoulou, E. Chrysomali, M. Iakovou, G. A. Garinis, and A. Karameris, “Elevated serum levels of the apoptosis related molecules TNF-α, Fas/Apo-1 and Bcl-2 in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 33, no. 7, pp. 386–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Thongprasom, K. Dhanuthai, W. Sarideechaigul, P. Chaiyarit, and M. Chaimusig, “Expression of TNF-α in oral lichen planus treated with fluocinolone acetonide 0.1%,” Journal of Oral Pathology and Medicine, vol. 35, no. 3, pp. 161–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Khan, C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman, “Th1 cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 77–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. Tracey and A. Cerami, “Tumor necrosis factor: a pleiotropic cytokine and therapeutic target,” Annual Review of Medicine, vol. 45, pp. 491–503, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. H. T. Idriss and J. H. Naismith, “TNFα and the TNF receptor superfamily: structure-function relationship(s),” Microscopy Research and Technique, vol. 50, no. 3, pp. 184–195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Weiss, M. Grell, B. Hessabi et al., “Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site,” Journal of Immunology, vol. 158, no. 5, pp. 2398–2404, 1997. View at Google Scholar · View at Scopus
  9. R. Lucas, I. Garcia, Y. R. A. Donati et al., “Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells,” European Journal of Immunology, vol. 28, no. 11, pp. 3577–3586, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hess and H. Engelmann, “A novel function of CD40: induction of cell death in transformed cells,” Journal of Experimental Medicine, vol. 183, no. 1, pp. 159–167, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Grell, G. Zimmermann, E. Gottfried et al., “Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF,” The EMBO Journal, vol. 18, no. 11, pp. 3034–3043, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Miklòs Jr. and M. S. Gruschwitz, “In situ expression and serum levels of tumour necrosis factor alpha receptors in patients with lichen planus,” Acta Dermato-Venereologica, vol. 77, no. 3, pp. 191–193, 1997. View at Google Scholar · View at Scopus
  13. E. Kaufman and I. B. Lamster, “The diagnostic applications of saliva—a review,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 2, pp. 197–212, 2002. View at Google Scholar · View at Scopus
  14. Y. Zhang, M. Lin, S. Zhang et al., “NF-κB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population,” Cytokine, vol. 41, no. 2, pp. 144–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Liu, H. Dan, Z. Wang et al., “IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic chinese population,” Inflammation, vol. 32, no. 3, pp. 176–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. L. Rhodus, B. Cheng, S. Myers, W. Bowles, VU. Ho, and F. Ondrey, “A comparison of the pro-inflammatory, NF-κB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients,” Clinical Immunology, vol. 114, no. 3, pp. 278–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ghallab and O. Shaker, “Salivary-soluble CD44 levels in smokers and non-smokers with chronic periodontitis: a pilot study,” Journal of Periodontology, vol. 81, no. 5, pp. 710–717, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. N. L. Rhodus, B. Cheng, W. Bowles, S. Myers, L. Miller, and F. Ondrey, “Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone,” Oral Diseases, vol. 12, no. 2, pp. 112–116, 2006. View at Publisher · View at Google Scholar
  19. P. Youngnak-Piboonratanakit, K. Dhanuthai, K. Thongprasom et al., “Expression of ifn-γ before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase,” Journal of Oral Pathology and Medicine, vol. 38, no. 9, pp. 689–694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Abramson, “The cornell medical index as an epidemiological tool,” American Journal of Public Health and the Nation's Health, vol. 56, no. 2, pp. 287–298, 1966. View at Google Scholar · View at Scopus
  21. M. Rad, M. A. Hashemipoor, A. Mojtahedi et al., “Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modified WHO diagnostic criteria,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 6, pp. 796–800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Carbone, E. Goss, M. Carrozzo et al., “Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up,” Journal of Oral Pathology and Medicine, vol. 32, no. 6, pp. 323–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Navazesh, “Methods for collecting saliva,” Annals of the New York Academy of Sciences, vol. 694, pp. 72–77, 1993. View at Google Scholar · View at Scopus
  24. X. A. Tao, C. Y. Li, N. L. Rhodus, J. Xia, X. P. Yang, and B. Cheng, “Simultaneous detection of IFN-gamma and IL-4 in lesional tissues and whole unstimulated saliva from patients with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 37, no. 2, pp. 83–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Al-Hashimi, M. Schifter, P. B. Lockhart et al., “Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 103, supplement 1, pp. S25.e1–S25.e12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. González-Moles and C. Scully, “Vesiculo-erosive oral mucosal disease—management with topical corticosteroids: (1) fundamental principles and specific agents available,” Journal of Dental Research, vol. 84, no. 4, pp. 294–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Lozada-Nur and C. Miranda, “Oral lichen planus: topical and systemic therapy,” Seminars in Cutaneous Medicine and Surgery, vol. 16, no. 4, pp. 295–300, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Fayyazi, S. Schweyer, A. Soruri et al., “T lymphocytes and altered keratinocytes express interferon-γ and interleukin 6 in lichen planus,” Archives of Dermatological Research, vol. 291, no. 9, pp. 485–490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. E. E. Karagouni, E. N. Dotsika, and A. Sklavounou, “Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 23, no. 1, pp. 28–35, 1994. View at Google Scholar · View at Scopus
  30. S. Pezelj-Ribaric, I. B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-Soskic, “Salivary levels of tumor necrosis factor-α in oral lichen planus,” Mediators of Inflammation, vol. 13, no. 2, pp. 131–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Simark Mattsson, M. Jontell, G. Bergenholtz, M. Heyden, and U. I. Dahlgren, “Distribution of interferon-γ mRNA-positive cells in oral lichen planus lesions,” Journal of Oral Pathology and Medicine, vol. 27, no. 10, pp. 483–488, 1998. View at Google Scholar · View at Scopus
  32. T. Yamamoto, T. Osaki, K. Yoneda, and E. Ueta, “Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 23, no. 7, pp. 309–315, 1994. View at Google Scholar · View at Scopus
  33. N. L. Rhodus, B. Cheng, S. Myers, L. Miller, V. Ho, and F. Ondrey, “The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus,” Molecular Carcinogenesis, vol. 44, no. 2, pp. 77–82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Smyth and R. W. Johnstone, “Role of TNF in lymphocyte-mediated cytotoxicity,” Microscopy Research and Technique, vol. 50, no. 3, pp. 196–208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. L. A. Tartaglia, R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, and D. V. Goeddel, “The two different receptors for tumor necrosis factor mediate distinct cellular responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 20, pp. 9292–9296, 1991. View at Google Scholar · View at Scopus
  36. M. Grell, F. M. Becke, H. Wajant, D. N. Männel, and P. Scheurich, “TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1,” European Journal of Immunology, vol. 28, no. 1, pp. 257–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Vandenabeele, W. Declercq, B. Vanhaesebroeck, J. Grooten, and W. Fiers, “Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells,” Journal of Immunology, vol. 154, no. 6, pp. 2904–2913, 1995. View at Google Scholar · View at Scopus
  38. W. Declercq, G. Denecker, W. Fiers, and P. Vandenabeele, “Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75,” Journal of Immunology, vol. 161, no. 1, pp. 390–399, 1998. View at Google Scholar
  39. V. Haridas, B. G. Darnay, K. Natarajan, R. Heller, and B. B. Aggarwal, “Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation,” Journal of Immunology, vol. 160, no. 7, pp. 3152–3162, 1998. View at Google Scholar · View at Scopus
  40. T. Weiss, M. Grell, K. Siemienski et al., “TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60,” Journal of Immunology, vol. 161, no. 6, pp. 3136–3142, 1998. View at Google Scholar · View at Scopus
  41. L. A. Tartaglia, D. Pennica, and D. V. Goeddel, “Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor,” Journal of Biological Chemistry, vol. 268, no. 25, pp. 18542–18548, 1993. View at Google Scholar · View at Scopus
  42. D. Vercammen, P. Vandenabeele, W. Declercq, M. van de Craen, J. Grooten, and W. Fiers, “Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF,” Cytokine, vol. 7, no. 5, pp. 463–470, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. F. K. M. Chan and M. J. Lenardo, “A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes,” European Journal of Immunology, vol. 30, no. 2, pp. 652–660, 2000. View at Google Scholar · View at Scopus